Gaithersburg, Maryland, November 15, 2022 /PRNewswire/ — YS Biopharma Co., Ltd. (“YS Biopharma” or the “Company”), a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations...
Gaithersburg, Maryland, November 10, 2022 /PRNewswire/ — YS Biopharma Co., Ltd. (“YS Biopharma” or the “Company”), a global biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations...
• Transaction values YS Biopharma at pre-money equity value of $834 million • Certain investors (“Forward Purchase Investors”) are expected to invest $30 million in a private placement concurrently...
Beijing, China – September 8, 2022 – YishengBio Co., Ltd., (“YishengBio”), a biopharmaceutical company dedicated to discovery, development, manufacturing and commercialization of new generations of vaccines and therapeutic biologics,...
Beijing, China – February 24, 2021 – YishengBio Co., Ltd. (“YishengBio”, the “Company”) announced today the closing of a US$130 million in Series B funding round. The new investment...
